Compare MBOT & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MBOT | EARN |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.6M | 173.2M |
| IPO Year | 2000 | 2012 |
| Metric | MBOT | EARN |
|---|---|---|
| Price | $2.34 | $4.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $7.50 | $5.38 |
| AVG Volume (30 Days) | ★ 1.4M | 371.6K |
| Earning Date | 05-13-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 20.56% |
| EPS Growth | ★ 60.27 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,887.00 | N/A |
| Revenue This Year | N/A | $7.69 |
| Revenue Next Year | $119.77 | $19.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $4.27 |
| 52 Week High | $4.62 | $6.08 |
| Indicator | MBOT | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 55.33 |
| Support Level | $1.99 | $4.43 |
| Resistance Level | $2.67 | $5.36 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 22.28 | 84.00 |
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.